The primary targets of CAB are MET (hepatocyte growth factor receptor, HGFR) and VEGFR2 (vascular endothelial growth factor receptor 2), which are both important mediators of tumor growth and tumor angiogenesis [10]. Here, KDR is linked to neoplasm.